Antigen-specific activation of T cells is initiated by engagement by the αβ T cell antigen receptor (TCR) of short peptides presented by major histocompatibility complex (MHC) molecules. In a structural symmetry that reflects the subdivided regions of the TCR and peptide-MHC (pMHC) surfaces, the TCR generally uses its germline-derived complementarity-determining region 1 (CDR1) and CDR2 loops to contact the polymorphic but genetically encoded MHC helices, while the CDR3 loops, derived through variable-diversity-joining (V(D)J) recombination, recognize mainly the peptide bound in the MHC groove. Although exceptions exist 1-3 , a large database of structures has revealed a loosely consistent docking topology (± ~110°) whereby the TCR α-chain sits over the amino-terminal region of the peptide and the α2 region or β1 region of MHC class I or MHC class II, respectively, and the TCR β-chain sits over the carboxy-terminal region of the peptide and α1 regions of both MHC classes 2 .
Antigen-specific activation of T cells is initiated by engagement by the αβ T cell antigen receptor (TCR) of short peptides presented by major histocompatibility complex (MHC) molecules. In a structural symmetry that reflects the subdivided regions of the TCR and peptide-MHC (pMHC) surfaces, the TCR generally uses its germline-derived complementarity-determining region 1 (CDR1) and CDR2 loops to contact the polymorphic but genetically encoded MHC helices, while the CDR3 loops, derived through variable-diversity-joining (V(D)J) recombination, recognize mainly the peptide bound in the MHC groove. Although exceptions exist [1] [2] [3] , a large database of structures has revealed a loosely consistent docking topology (± ~110°) whereby the TCR α-chain sits over the amino-terminal region of the peptide and the α2 region or β1 region of MHC class I or MHC class II, respectively, and the TCR β-chain sits over the carboxy-terminal region of the peptide and α1 regions of both MHC classes 2 .
The forces that shape the TCR-pMHC docking topology and cross-reactivity have been studied extensively without distinct resolution 2 . For docking topology, there has been substantial debate about structural evidence of a TCR bias toward MHC and, in particular, whether structurally similar interactions between germline-derived TCR CDR1 and CDR2 and conserved residues on MHC α-helices are genetically encoded and evolutionarily conserved signatures of MHC restriction 1, 2, [4] [5] [6] [7] [8] [9] [10] . This debate has been influenced by the observation of structural variances, or adaptability, in TCR-pMHC interactions 2 . This adaptability can be local (for example, restricted to individual loops and how they interface with MHC α-helices) or global (for example, resulting from alterations in TCR binding modes) [11] [12] [13] [14] .
The TCR-MHC interaction mode can be influenced by changes in peptide or MHC, alterations in the CDR3 loop, or use of different TCR α-chain variable region (V α ) or TCR β-chain variable region (V β ) domains 4, 5, 11, [15] [16] [17] [18] [19] [20] [21] [22] [23] . One difficulty in studying the determinants of TCR-pMHC docking topology is the complexity inherent in the TCR-pMHC interface, which is composed of composite surfaces that are functionally segregated but structurally and energetically cooperative 24 . Further complexity is added to the interpretation of structural data by the fact that thymic selection processes, including coreceptor involvement, might have pre-determined particular features of the interaction 25 that shape TCR-pMHC interactions observed in the context of peripheral T cells 26, 27 . In some contexts, TCRs can even recognize non-MHC antigens, a finding used to support the view that co-receptors can control the focus of TCRs on MHC ligands 28, 29 . Such observations, however, do not rule out the possibility of a role for a genetically imposed bias of TCRs toward MHC proteins, but they do indicate that such biases do not impose absolute specificity. Indeed, given the large repertoire of TCR sequences (>10 14 ), many 'non-canonical' binding modes probably exist 3 , but in the database of over 50 unique TCR-pMHC structures determined so far, the vast majority of the repertoire conforms to the general structural paradigm whereby germline-mediated interactions are a major component of pMHC recognition. A r t i c l e s TCR cross-reactivity has also been studied extensively, with divergent conclusions. On the one hand, TCRs have the ability to 'see' many different peptide antigens presented by MHC 12, [30] [31] [32] . On the other hand, upon close inspection, TCRs may be less cross-reactive than previously appreciated, as most cases of cross-reactivity seem to be explained by preservation of several key TCR contact residues in seemingly non-homologous peptides 23, 30, 33 .
Published work has considered TCR germline bias for MHC, cross-reactivity, and signaling independently. Taking into account structural and energetic inter-relationships might prove beneficial for full understanding of TCR-pMHC recognition and signaling. Here we used the mouse 42F3 TCR, which recognizes the MHC class I molecule H-2L d (ref. 1), as a model system to further clarify the interplay between TCR cross-reactivity and germline specificity. We used pMHC libraries displayed on yeast to screen recombinant, multimeric 42F3 TCR in a cell-free environment, free of any constraints on binding, and isolated recognized peptides with limited homology to the cognate antigen.
By characterizing the binding, signaling and structural properties of TCR-pMHC complexes with limited homology, we found that despite diversity in the peptide sequences it recognized, the 42F3 TCR maintained very similar 'hot-spot' contacts with the most prominent up-facing peptide residues, which resulted in a high degree of crossreactivity with retention of specificity for key positions. Furthermore, while the TCR adjusted its binding mode to engage different peptides, rather than 'seeing' a spectrum of disparate binding solutions, the V β domain of the TCR ratcheted between two 'preferred' positions over the MHC α1 helix while retaining interaction between the MHC α2 helix and the TCR V α that was almost completely superimposable in 12 structures of V α 3 TCR with H-2L d . On the basis of these studies, we propose a model that functionally integrates conserved interactions between TCR germline regions and MHC helices and peptide cross-reactivity in which genetically imprinted biases toward the MHC help to 'steer' TCR binding solutions but still permit the structural adaptability needed for cross-reactivity. 34) , use a single-chain configuration in which the carboxyl terminus of the mini-MHC is fused to the amino terminus of the nine-amino acid peptide 1 . Selection identified epitopes that mimic ('mimotopes') the cognate antigen QL9 (amino acid sequence, QLSPFPFDL), but all agonists identified shared obvious sequence homologies with QL9 and, upon crystallographic study, shared very similar TCR docking footprints 1 . We suspected the scaffold design might have limited the recovery of diverse peptide sequences, indicated by the very weak staining of H-2L d -m31 fused to QL9 (QL9-m31) by 42F3 TCR tetramers 1 .
RESULTS
Since we sought to find peptide sequences with greater divergence from the cognate antigen QL9 to better 'stress test' TCR-pMHC recognition in the face of alternative peptide-recognition chemistries, we developed a second-generation 'mini-MHC' yeast display scaffold linking the carboxyl terminus of the peptide to the MHC molecule (Fig. 1a) . The MHC molecule included substitution of alanine for the tyrosine at position 84 that opened a path at the carboxyterminal end of the groove to accommodate a linker ( Supplementary  Fig. 1a) , as originally shown for pMHC single-chain trimers 35 . However, in this orientation, the carboxyl terminus of the peptide was far from the amino terminus of the MHC molecule and would require a long connecting linker. Therefore, we circularly permuted the MHC molecule to relocate the amino and carboxyl termini of the MHC molecule closer to the carboxyl terminus of the peptide (Supplementary Fig. 1 ).
To circularly permute the MHC, we interrupted the sequence at a loop near the carboxyl terminus of the peptide so that H-2L d residue 120 became the new carboxyl terminus and Cys121 became the new amino terminus, while at the same time we fused the former carboxy-terminal residue 180 to the former amino-terminal residue 1 with a short glycine-serine linker (Supplementary Fig. 1 ). To avoid spontaneous formation of intermolecular disulfide bonds, we altered the new amino terminus with substitution of serine for the cysteine at position 121. Fig. 1b) , which suggested that QL9-m31r-CP was displayed on the yeast surface but was incorrectly folded. To restore the native fold, we evolved the m31r-CP design by creating a pool of ~1 × 10 8 variants produced by errorprone PCR and selecting for gain-of-function mutations that recovered recognition by the cognate TCRs (Supplementary Fig. 1b ). We found a subset of circularly permuted scaffold clones that contained only interface and peptide-distal substitutions and recognized both 2C TCR tetamers and 42F3 TCR tetamers. The clone with the brightest TCR tetramer staining was m31r-CP-E3 (Supplementary Fig. 1c ). The two substitutions selected (replacement of tyrosine for the aspartic acid at position 122 and replacement of threonine for the alanine at position 136) in this scaffold variant occurred in the proximity of the linker-MHC junction, which perhaps accommodated the artificial linker or stabilized the new MHC fold-initiating sequence (Supplementary Fig. 1c) . We proceeded to construct new libraries to select for peptides presented by the circularly permuted MHC scaffold.
Peptide specificity of the 42F3 TCR We created a 'random' peptide library tethered to m31r-CP-E3 ( Fig. 1a and Supplementary Fig. 1a-d) . The diversity of this 'random' nineamino acid library was limited at anchor positions P2 (proline) and P9 (phenylalanine, isoleucine, leucine and methionine) to reflect the natural 'preference' of H-2L d -presented peptides 36 (Fig. 1b) . For selection, we used streptavidin-coated magnetic beads 30 saturated with biotinylated 42F3 TCR to allow enrichment of yeast clones from a library of 4.2 × 10 8 peptide variants (Fig. 1b,c and Supplementary Fig. 1e ). We recovered a range of peptides different in sequence from each other and from the native agonist QL9 (Fig. 1c,d and Supplementary Fig. 1f ). We sequenced several hundred clones from the final selected pool and observed a high degree of sequence diversity in all positions except positions P6 and P7. P7 was uniformly a large hydrophobic residue, as in QL9 (Fig. 1c,d ). P6 exhibited a strong bias toward proline and glycine, as in QL9, but allowed substitution with tryptophan and glutamic acid (Fig. 1c,d) . The P5-P6-P7 sequence stretch in QL9 forms an arch that peaks at P7 and most intimately contacts CDR3β through apolar and van der Waals interactions 1 . Collectively, there seemed to be selective pressure to preserve this interaction mode while allowing diverse chemistries at other positions (Fig. 1c,d ). We sub-classified the sequences into related families and synthesized ten peptides for characterization, including five for structural characterization, whose sequences were suitably divergent from each other, from the cognate antigen QL9, and from the peptides derived from the published libraries 1 .
Signaling properties of library-selected peptides
We screened CD8 − and CD8 + 42F3 T cells for their production of interleukin 2 (IL-2) after stimulation with antigen-presenting cells presenting a subset of divergent peptides that arose from the secondgeneration selections and compared them to the QL9 mimotopes that arose from the first-generation libraries (Fig. 2a) . We transduced 58α − /β − mouse T cell hybridoma cells to express the 42F3 TCR and assessed their IL-2 responses to peptides presented at a dose of 10 µM on antigen-presenting cells. Unlike the lone non-agonist peptide selected (p3A1; sequence, SPLDSLWWI) from the firstgeneration library, the majority of peptides selected from the secondgeneration library elicited substantial IL-2 responses in these cells (Fig. 2a) . The synthetic peptide antigens had a range of dependence on the co-receptor CD8 on the basis of our initial screen, as several second-generation peptides failed to stimulate or weakly stimulated cells in the absence of CD8 at this high peptide dose (Fig. 2a) .
We titrated the IL-2 responses of CD8 + 42F3 T cells for various agonist peptides with diverse sequences. For this set, we observed responses to IL-2 across a several-log range of EC 50 values (effector concentration for a half-maximum response) (Fig. 2b, Table 1 and Supplementary Fig. 2) . Additionally, we assessed the affinity and 
Figure 2 Supplementary Fig. 2 ) of CD8 + 42F3 T cells, plotted against the affinity of 42F3 TCRpMHC interactions. pCPE3 is a weak agonist for which EC 50 and E max were not determined and was therefore omitted from this analysis. Data are representative of two experiments (mean and s.e.m. n = 2 of technical replicates in a).
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A r t i c l e s kinetics of the binding of the 42F3 TCR to each 'titrated' peptide by surface plasmon resonance (Fig. 2b, Table 1 and Supplementary  Fig. 3a-c) . As expected, we found that the 42F3 TCR-pMHC complexes with the highest affinity in the second-generation libraries were potent stimulators of IL-2 responses, but we also observed high-affinity ligands (pCPC5 and pCPA12) that produced partial IL-2 responses, as well as a ligand of moderate affinity (p4B10) that potently stimulated IL-2 responses in CD8 + 42F3 T cells expressing the 42F3 TCR (Fig. 2b) .
We were able to sub-divide the 42F3 TCR agonists into two categories. We defined 'potent agonists' as those peptides that elicited equally strong IL-2 responses in the presence of CD8 and absence of CD8 in our screen, and 'CD8-dependent agonists' as those that required CD8 to maximally stimulate IL-2 production (Fig. 2a) . While the potent agonists all produced high maximal IL-2 responses, the CD8-dependent agonists elicited a range of maximal responses, including high (p5E8), medium (pCPA12) and low (QL9 and pCPC5), in 58α − /β − cells transduced with CD8 and 42F3 TCR (Fig. 2b) .
One caveat to the stimulation data is that we do not know the relative loading efficiencies or binding affinities of the peptides for H-2L d on the cell surface, and these differences could have been involved in the relative differences in stimulation potencies. However, all of the peptides had preserved optimal MHC-binding anchors at positions P2 and P9 and were presented well in the single-chain format on yeast, so we suspect they were loaded onto the MHC. Collectively, the ability of the peptides studied to load into naturally occurring H-2L d , to allow binding in affinity ranges expected for TCR-pMHC interactions, and to induce signaling confirmed the utility of using the m31r-CP-E3 'mini' H-2L d as a system for identifying peptides of interest.
Peptide degeneracy of the 42F3 TCR We crystallized five 42F3 TCR complexes bound to a mini-H-2L d scaffold (m31r) presenting the newly identified peptides (Fig. 3b,  Supplementary Fig. 4a,b and Supplementary Table 1 ) and compared those structures with the structures of 'wild-type' QL9 ( Fig. 3a) and four previously characterized 42F3 TCR-pMHC complexes 1 ( Fig. 3c and Supplementary Fig. 4c,d) . The refolded m31r variant lacked the engineered linkers, circular permutation and synthetically evolved 'stabilizing' substitutions, which allowed us to study structures more representative of 'naturally' presented peptide, as when we tested for activity (Fig. 2) . Notably, every selected peptide assayed was recognized by the 42F3 TCR in both presentation formats (i.e., covalently linked in the selection scaffold, and as free peptide refolded with MHC) (Figs. 2 and 3) . For each structure solved, the peptide backbone and side-chain electron density were well defined ( Supplementary Fig. 4) .
To visualize the adaptive molecular determinants of peptide cross-reactivity by the 42F3 TCR CDR3 loops, we comprehensively compared the CDR3-peptide contacts of both the first-generation complexes and the second-generation complexes (Fig. 3b,c) . Each peptide was recognized by a unique pattern of pair-wise contacts with the TCR CDR3 loops (Fig. 3b,c) . Generally, the CDR3β loop contributed more to peptide recognition than the CDR3α did, probably due to the arch in the peptide at residues lying underneath CDR3β 1 (Fig. 3b,c) . In contrast, the CDR3α contacts npg were in general fewer and more diverse in each complex, consistent with the lack of sequence specificity at peptide positions P1-P4 (Figs. 1d  and 3b,c) . Overall, it seemed that the arch in the carboxy-terminal region of the peptide enforced close contact with CDR3β of the 42F3 TCR, while the 'lower-lying' amino-terminal peptide residues were more distant from CDR3α and permitted more sequence diversity in this region. In two complexes (with QL9 and pCPB7), CDR3α did not make contact with the peptide 1 (Fig. 3b,c) . Peptide conformation had a critical role in establishing contacts, as the peptide backbone, rather than its side chains, were typically recognized by the 42F3 TCR (Fig. 3b,c) . For example, Lys95α of the 42F3 TCR frequently contacted the amide backbone of the peptide presented (for five of nine complexes), while Asp95β of the 42F3 TCR frequently formed a hydrogen bond through its backbone carbonyl to the amide of position P8 (for four of nine complexes) (Fig. 3b,c) .
The most consistent set of van der Waals contacts within this set of complexes arose from hydrophobic residues at peptide position P7 to the Asp95-Ala96-Pro97 motif of the CDRβ3 loop (Fig. 3b,c) . Since Pro97 restricted the dihedral angles of the loop, the CDR3β remained fixed in conformation in all nine complexes 1 (Fig. 3b,c) . 

A r t i c l e s
Other peptide positions whose sequences were biased in our enriched peptide pools (Fig. 1d) did not result in conserved contacts to the 42F3 TCR (Fig. 3b,c) . For example, the 'preferred' acidic amino acid at P4 correlated with potent IL-2 responses but failed to show conserved contacts across these complexes (Fig. 3b,c) . In the complexes with pCPB9 or p4B10, the acidic P4 side chain formed hydrogen bonds to Ser99α or Gly96α, respectively, of the 42F3 TCR, (Fig. 3b,c) . In the complex with pCPB7, the Glu4 position did not seem to make contact with the CDR3α loop (Fig. 3b,c) . Similarly, while our structural set included five complexes with peptides with the 'preferred' aspartic acid at P8, the contacts made by this residue varied from hydrogen bonding to van der Waals contacts to no contact with the TCR (Fig. 3b,c) . Although we observed some amino acid 'preferences' at positions P4-P6 for recognition by the 42F3 TCR (Fig. 1c,d) , only the 'preferred' hydrophobic amino acid at P7 resulted in conserved TCR-peptide interactions in agonist complexes (Fig. 3b,c) .
Germline recognition in stimulatory receptor geometries
We next assessed how the TCR-MHC docking topology was modulated by the diverse agonist peptides derived from our selections. Combined, the nine complexes with the 42F3 TCR (one nonagonist and eight agonist) produced three main docking topologies at angles of 84°, 64° and 27° (Fig. 4a) . The 27° angle noted for a nonagonist peptide has been characterized 1 , so here we focused on the eight agonist peptides. The most frequent docking mode, including each of the CD8-dependent agonists complexes (QL9, p5E8, pCPA12, pCPC5 and pCPE3) and partial agonist complexes (QL9, pCPA12, pCPC5 and pCPE3), was 64° relative to the peptide (Fig. 4a) . Notably, two potent agonist peptide-MHC complexes assumed an alternative docking geometry with a similar V α 3.3 contact but a shifted V β 8.3 footprint, which rotated the TCR to ~84° (Figs. 3b and 4a) . These two peptides (pCPB7 (WPAEGGFQL) and pCPB9 (SPAEAGFFL)) contained six identical residues among the nine total residues, including a glutamic acid at P4 and a glycine at P6. Residues at these positions differed from those in the peptides that exhibited the 64° docking angle (Figs. 3  and 4a) . One possible explanation for this might be that the presence of a glycine at P6 provided sufficient flexibility of the peptide backbone to allow the TCR to pivot by 20°. Nevertheless, the slippage of the TCR-pMHC geometry from the 64° docking angle to the 84° docking angle did not seem to affect the maximal stimulatory potential of the TCR-pMHC complexes, as agonists with 84° TCR-docking geometries elicited IL-2 responses equivalent to that of the strongest potent agonist with a 64° docking angle: p4B10 (Figs. 2 and 4a) . We therefore observed three peptide-induced docking modes by which the 42F3 TCR was able to engage H-2L d , two of which were able to maximally stimulate IL-2 responses and one (previously reported) that failed to stimulate 42F3 T cells 1 .
Notably, all agonist complexes, including published complexes of the 2C TCR with H-2L d (refs. 12,37) , shared a recognition motif that was nearly completely atomically superimposable, mediated through the V α 3.3 domain, in which Tyr31α and Tyr50α of the 42F3 TCR buried Tyr155 of the MHC, and Ser51α of the 42F3 TCR formed hydrogen bonds to the Glu154 backbone ( Fig. 4b and Supplementary Fig. 5a ). The overall root-mean-square deviation of these three residues ranged from 0.9Å to 2.2Å compared with that of the 42F3-QL9-H-2L d TCRpMHC complex (data not shown). In contrast, the V β positions formed two groups, at a docking angle of either 64° or 84° (Fig. 4a) . For the docking angle of 64°, 42F3 TCR V β consistently used Asn30β, Tyr50β and Ala52β to interact with the H-2L d α1 helix at Gln72, Trp73, Ala76 and Arg79 (Supplementary Fig. 5b ). For the docking angle of 84°, 42F3 TCR V β used Gln31β, Tyr50β and Gln71β to contact Gln65, Lys68, Gln72, Val76 and Arg79 of the H-2L d α1 helix (Supplementary Fig. 5b) . We therefore observed a pivot mechanism that facilitated peptide cross-reactivity in which two V β motifs for contact with the MHC accommodated diverse agonistic peptides, while the dominant V α 3 germline contacts were conserved across all agonist complexes studied for 2C, 2C variants and 42F3 TCRs recognizing H-2L d (Fig. 4c and Supplementary Table 2 ).
DISCUSSION
The data we have presented here, together with published structures of the 42F3 and 2C TCRs and their variants bound to H-2L d -QL9 (refs. 1,12,37) , constitute a structural database of 12 TCRs bearing a common germline element (V α 3) and engaging a common MHC molecule (H-2L d ). This collection of 12 TCR-pMHC complexes is reflective of the general features of most TCR-pMHC interactions, as seen in the database of more than 50 published TCR-peptide-MHC class I and TCR-peptide-MHC class II structures. Unquestionably, given the extremely large combinatorial diversity of the TCR repertoire, deviations from these generalizations can be expected. Nevertheless, several conclusions about TCR cross-reactivity and germline recognition have emerged from our analysis here that are in accord with the majority of the overall structural database.
In terms of TCR cross-reactivity, we found that the 42F3 TCR did indeed recognize a wide range of peptides with limited homology to the cognate peptide QL9. However, while this would appear to support the concept that the TCR promiscuously recognizes many diverse peptides in a biological milieu 31, 32, [38] [39] [40] [41] , close inspection of the chemistry in the TCR-pMHC interfaces revealed a more nuanced reality. Despite sequence variability, the 42F3 TCR repeatedly focused on structurally and chemically similar elements of the peptides, most commonly using the CDR3β Asp-Ala-Pro motif to engage 'preferred' hydrophobic residues at position P7. Recognition by the 42F3 TCR was therefore highly focused on a single apical peptide residue, with a wide range of chemistries and conformations used to accommodate the diversity at the remaining accessible positions. The limited interaction of the 42F3 TCR with the peptide's amino terminus relaxed overall peptide specificity, which allowed recovery of a larger number of peptide sequences. It is possible, in fact it is likely, that an H-2L d library with varied peptide lengths or MHC anchor residues could be used to identify peptides with substantially different TCR-binding solutions. However, we believe that our results reflect the general properties of most TCRpMHC interactions. The scope and nature of cross-reactivity is consistent with published data focused on the recognition of MHC class II molecules by TCRs 30 . Collectively, these data suggest that TCRs are more specific than previously appreciated and lead to a more granular definition of cross-reactivity as being rooted in highly specific peptide hot spots that enable relaxed specificities at ancillary positions.
The conclusions of these studies reflect a fundamental feature of protein-protein interfaces: engagement of a small number of structurally and energetically important hot spots, typically near the interface center, surrounded by weaker and more diverse peripheral interactions 17, 30, 42 . Inspection of the amino acid sequences of peptides recognized by the 42F3 TCR in the absence of structural information would suggest degeneracy, while in fact recognition is focused on key features shared by recognized peptides. Although CDR3-peptide hot spots in TCR-pMHC interfaces have been discussed 17, 43 , the observation that the same hot spot was repeatedly engaged in the 42F3 system, together with visualization of how sequence diversity was tolerated, allows better understanding of the nature of TCR crossreactivity. This mechanism ensures the ability to engage large numbers npg of diverse peptides with retention of specificity for at least one structural and chemically homologous position. We suggest that parsing of the TCR-pMHC interface into hot-spot residues and non-hot-spot residues contributes substantially to the dichotomy of cross-reactivity and specificity that characterizes TCR recognition 2, 30 .
With respect to germline recognition, we observed a striking, nearatomical superimposition of the interaction between V α 3.3 and the H-2L d α2 helix in 12 structures with different peptides, V β segments and CDR3 loops. The repeated observation of this interaction, in the presence of considerable local and global structural variation, was probably reflective of the 'imprint' of TCR-MHC co-evolution, in this case a favorable 'patch' between V α 3.3 and H-2L d . For the 42F3 TCR, these interactions seemed to dominate over the V β interactions, which permitted the observed ratcheting of V β along the α1 helix (dominant roles for α-chains in TCR binding have been observed before 44 ). The inherent adaptability or 'give' available to TCR-MHC germline interactions is illustrated by the non-agonist peptide p3A1, whose Trp-Trp motif occludes the 'preferred' docking site for V α 3.3, which results in a 'peptide-centric geometry' 1 . Similar circumstances might be found with long or otherwise unusually 'bulged' peptides 22, 45 .
Our observations suggest an interplay between TCR-MHC germline bias and its potential influence on cross-reactivity. It has been shown that alterations in TCR-docking modes can facilitate crossreactivity 1, [11] [12] [13] 33 and that CDR3 loops can affect TCR-MHC contacts through 'CDR3 editing' 46 . Consistent with published results 1,30,33 , we also observed that different peptides yielded different binding modes even with the same TCR and MHC. However, rather than seeing the spectrum of binding topologies that would be expected from a purely 'opportunistic' system, we observed distinct, discrete binding modes for peptides in the form of ratcheting of 42F3 TCR V β along the H-2L d α1 helix or, equivalently, 'preferences' of the 42F3 TCR for particular binding orientations. The existence of these structural 'preferences' , even in the case of the alloreactive TCR-MHC pair of the 42F3 TCR and H-2L d that did not encounter each other during T cell development, supports the proposal of co-evolution of TCR and MHC. However, notably, these observations also support the proposal of the presence of a genetically encoded adaptability that can facilitate cross-reactivity. In this case, the orientations of 42F3 TCR V β probably stemmed from a combination of germline-encoded attractive interactions and repulsive interactions at 'preferred' orientations and 'non-preferred' orientations, respectively. From these data, we propose a model for engagement by the TCR that integrates germline bias and peptide recognition. TCRs are clearly adaptable, even capable of engaging in non-productive binding modes and, under certain circumstances, of binding non-MHC ligands 1, 28, 29, 47 .
We suggest the existence of 'preferred' but weak V α or V β interaction points along MHC helices that bias TCRs toward, but do not obligate, discrete binding solutions. Chemically, this could arise from the incorporation of multi-functional amino acids such as tyrosine and the strategic placement of charges or hydrogen-bond donors and acceptors, as seen with the interaction points between the 42F3 TCR and H-2L d . The resulting structural biases would help to focus binding while still permitting structural adaptations as the CDR3 loops accommodate peptide hot spots. In this way, the mechanisms of TCR cross-reactivity and germline bias are cooperative processes in shaping the recognition of pMHC complexes.
METHODS
Methods and any associated references are available in the online version of the paper. 
